112 related articles for article (PubMed ID: 21937405)
1. Small hepatocellular carcinoma in Chinese patients.
Carr BI; Lu SN; Pancoska P
Hepatogastroenterology; 2011; 58(109):1334-42. PubMed ID: 21937405
[TBL] [Abstract][Full Text] [Related]
2. Small HCCs identified by screening.
Pancoska P; De Giorgio M; Fagiuoli S; Carr BI
Dig Dis Sci; 2011 Oct; 56(10):3078-85. PubMed ID: 21465143
[TBL] [Abstract][Full Text] [Related]
3. Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma.
Carr BI; Guerra V; Pancoska P
Oncology; 2012; 83(6):339-45. PubMed ID: 23006937
[TBL] [Abstract][Full Text] [Related]
4. Low alpha-fetoprotein HCC and the role of GGTP.
Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F
Int J Biol Markers; 2014 Dec; 29(4):e395-402. PubMed ID: 24832180
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase.
Carr BI; Guerra V
Oncology; 2013; 85(3):153-9. PubMed ID: 23988857
[TBL] [Abstract][Full Text] [Related]
6. Features of massive hepatocellular carcinomas.
Carr BI; Guerra V
Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):101-8. PubMed ID: 23863262
[TBL] [Abstract][Full Text] [Related]
7. Significance of increased serum GGTP levels in HCC patients.
Carr BI; Pancoska P; Branch RA
Hepatogastroenterology; 2010; 57(101):869-74. PubMed ID: 21033244
[TBL] [Abstract][Full Text] [Related]
8. HCC in older patients.
Carr BI; Pancoska P; Branch RA
Dig Dis Sci; 2010 Dec; 55(12):3584-90. PubMed ID: 20238246
[TBL] [Abstract][Full Text] [Related]
9. Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.
Giannini EG; Sammito G; Farinati F; Ciccarese F; Pecorelli A; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Gasbarrini A; Sacco R; Foschi FG; Missale G; Morisco F; Svegliati Baroni G; Virdone R; Trevisani F;
Cancer; 2014 Jul; 120(14):2150-7. PubMed ID: 24723129
[TBL] [Abstract][Full Text] [Related]
10. Significance of platelet and AFP levels and liver function parameters for HCC size and survival.
Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Int J Biol Markers; 2014 Sep; 29(3):e215-23. PubMed ID: 24526315
[TBL] [Abstract][Full Text] [Related]
11. Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: a cross-sectional case-control study from Chinese patients with HBV infection.
Gao C; Fang L; Zhao HC; Li JT; Yao SK
Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):385-93. PubMed ID: 23924496
[TBL] [Abstract][Full Text] [Related]
12. Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.
Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Ludovico Rapaccini G; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Semin Oncol; 2014 Apr; 41(2):252-8. PubMed ID: 24787296
[TBL] [Abstract][Full Text] [Related]
13. HCC in young adults.
Carr BI; Pancoska P; Branch RA
Hepatogastroenterology; 2010; 57(99-100):436-40. PubMed ID: 20698204
[TBL] [Abstract][Full Text] [Related]
14. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma.
Liu C; Xiao GQ; Yan LN; Li B; Jiang L; Wen TF; Wang WT; Xu MQ; Yang JY
World J Gastroenterol; 2013 Mar; 19(11):1811-9. PubMed ID: 23555170
[TBL] [Abstract][Full Text] [Related]
15. Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.
Yang JD; Dai J; Singal AG; Gopal P; Addissie BD; Nguyen MH; Befeler AS; Reddy KR; Schwartz M; Harnois DM; Yamada H; Gores GJ; Feng Z; Marrero JA; Roberts LR
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1085-1092. PubMed ID: 28258053
[No Abstract] [Full Text] [Related]
16. HCC and its microenvironment.
Carr BI; Guerra V
Hepatogastroenterology; 2013 Sep; 60(126):1433-7. PubMed ID: 23933936
[TBL] [Abstract][Full Text] [Related]
17. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.
El-Serag HB; Kanwal F; Davila JA; Kramer J; Richardson P
Gastroenterology; 2014 May; 146(5):1249-55.e1. PubMed ID: 24462733
[TBL] [Abstract][Full Text] [Related]
18. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
19. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
20. A Hepatocellular Carcinoma Aggressiveness Index and Its Relationship to Liver Enzyme Levels.
Carr BI; Guerra V
Oncology; 2016; 90(4):215-20. PubMed ID: 26974336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]